(ITP) Interparfums - Ratings and Ratios
Fragrances, Skincare, Gift Sets
Dividends
| Dividend Yield | 4.63% |
| Yield on Cost 5y | 4.72% |
| Yield CAGR 5y | 27.87% |
| Payout Consistency | 89.6% |
| Payout Ratio | 62.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 32.7% |
| Value at Risk 5%th | 51.0% |
| Relative Tail Risk | -5.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.22 |
| Alpha | -38.85 |
| CAGR/Max DD | -0.26 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.460 |
| Beta | 0.323 |
| Beta Downside | 0.444 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.61% |
| Mean DD | 25.60% |
| Median DD | 27.84% |
Description: ITP Interparfums November 08, 2025
Interparfums SA (ticker ITP) is a Paris-based company that designs, manufactures and distributes perfumes and cosmetics under license agreements with a portfolio of luxury and fashion houses-including Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Lacoste, Montblanc, Moncler, Rochas, S.T. Dupont and Van Cleef & Arpels-across Europe, the Americas, Africa, the Middle East and Asia. The business is split into two segments, Fragrances and Fashion, and reaches consumers through wholly-owned subsidiaries, joint ventures, independent distributors, cosmetics subsidiaries and duty-free operators.
Key industry context: the global fragrance market is projected to grow at a compound annual growth rate (CAGR) of roughly 4-5 % through 2029, driven by rising disposable income in emerging markets and a shift toward premium-priced scents. Interparfums reported FY 2023 revenue of approximately €500 million, with a modest 5 % year-over-year increase, reflecting both organic growth and the recent acquisition of additional licensing rights. A material driver of earnings is the company’s exposure to luxury-goods consumer sentiment, which can be sensitive to macro-economic factors such as GDP growth rates and currency fluctuations (euro-vs-USD).
For a deeper, data-rich perspective on Interparfums’ valuation and risk profile, you may find it worthwhile to explore the company’s profile on ValueRay, where the platform aggregates comparable peer metrics and forward-looking scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (237.8m TTM) > 0 and > 6% of Revenue (6% = 92.3m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -3.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.53% (prev 27.88%; Δ -4.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 99.9m <= Net Income 237.8m (YES >=105%, WARN >=100%) |
| Net Debt (89.8m) to EBITDA (366.2m) ratio: 0.25 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (83.8m) change vs 12m ago 10.34% (target <= -2.0% for YES) |
| Gross Margin 65.71% (prev 65.49%; Δ 0.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 156.9% (prev 123.7%; Δ 33.26pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 28.70 (EBITDA TTM 366.2m / Interest Expense TTM 11.4m) >= 6 (WARN >= 3) |
Altman Z'' 7.17
| (A) 0.36 = (Total Current Assets 533.7m - Total Current Liabilities 171.6m) / Total Assets 992.5m |
| (B) 0.07 = Retained Earnings (Balance) 73.1m / Total Assets 992.5m |
| (C) 0.33 = EBIT TTM 328.1m / Avg Total Assets 980.4m |
| (D) 2.18 = Book Value of Equity 679.6m / Total Liabilities 311.7m |
| Total Rating: 7.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.59
| 1. Piotroski 5.50pt |
| 2. FCF Yield 3.94% |
| 3. FCF Margin 5.34% |
| 4. Debt/Equity 0.26 |
| 5. Debt/Ebitda 0.25 |
| 6. ROIC - WACC (= 23.62)% |
| 7. RoE 35.97% |
| 8. Rev. Trend 64.85% |
| 10. EPS Trend data missing |
What is the price of ITP shares?
Over the past week, the price has changed by +1.06%, over one month by -9.67%, over three months by -17.58% and over the past year by -31.85%.
Is ITP a buy, sell or hold?
What are the forecasts/targets for the ITP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.1 | 21.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.9 | 0.2% |
ITP Fundamental Data Overview November 27, 2025
Market Cap EUR = 2.00b (2.00b EUR * 1.0 EUR.EUR)
P/E Trailing = 14.2262
P/E Forward = 15.3139
P/S = 2.2087
P/B = 2.9577
Beta = 1.2
Revenue TTM = 1.54b EUR
EBIT TTM = 328.1m EUR
EBITDA TTM = 366.2m EUR
Long Term Debt = 118.2m EUR (from longTermDebt, last quarter)
Short Term Debt = 49.5m EUR (from shortTermDebt, last quarter)
Debt = 176.9m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 89.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.09b EUR (2.00b + Debt 176.9m - CCE 90.1m)
Interest Coverage Ratio = 28.70 (Ebit TTM 328.1m / Interest Expense TTM 11.4m)
FCF Yield = 3.94% (FCF TTM 82.2m / Enterprise Value 2.09b)
FCF Margin = 5.34% (FCF TTM 82.2m / Revenue TTM 1.54b)
Net Margin = 15.45% (Net Income TTM 237.8m / Revenue TTM 1.54b)
Gross Margin = 65.71% ((Revenue TTM 1.54b - Cost of Revenue TTM 527.6m) / Revenue TTM)
Gross Margin QoQ = 65.91% (prev 65.60%)
Tobins Q-Ratio = 2.10 (Enterprise Value 2.09b / Total Assets 992.5m)
Interest Expense / Debt = 1.97% (Interest Expense 3.48m / Debt 176.9m)
Taxrate = 25.40% (24.9m / 97.9m)
NOPAT = 244.8m (EBIT 328.1m * (1 - 25.40%))
Current Ratio = 3.11 (Total Current Assets 533.7m / Total Current Liabilities 171.6m)
Debt / Equity = 0.26 (Debt 176.9m / totalStockholderEquity, last quarter 679.6m)
Debt / EBITDA = 0.25 (Net Debt 89.8m / EBITDA 366.2m)
Debt / FCF = 1.09 (Net Debt 89.8m / FCF TTM 82.2m)
Total Stockholder Equity = 661.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 23.96% (Net Income 237.8m / Total Assets 992.5m)
RoE = 35.97% (Net Income TTM 237.8m / Total Stockholder Equity 661.0m)
RoCE = 42.12% (EBIT 328.1m / Capital Employed (Equity 661.0m + L.T.Debt 118.2m))
RoIC = 30.36% (NOPAT 244.8m / Invested Capital 806.3m)
WACC = 6.74% (E(2.00b)/V(2.18b) * Re(7.21%) + D(176.9m)/V(2.18b) * Rd(1.97%) * (1-Tc(0.25)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 5.04%
[DCF Debug] Terminal Value 80.98% ; FCFE base≈94.3m ; Y1≈112.6m ; Y5≈178.2m
Fair Price DCF = 36.45 (DCF Value 3.05b / Shares Outstanding 83.6m; 5y FCF grow 20.70% → 3.0% )
Revenue Correlation: 64.85 | Revenue CAGR: 38.12% | SUE: 1.50 | # QB: 1
EPS next Year (2026-12-31): EPS=1.45 | Chg30d=-0.137 | Revisions Net=-4 | Growth EPS=-6.5% | Growth Revenue=-0.1%